Consistent with the outlined molecular mechanisms of how KIF2C fuels the malignancy of HCC cells, a large number of investigations have been able to correlate highly expressed KIF2C in HCC patients with several clinicopathological characteristics (Figure 3(C) and Table 1). Here, KIF2C is linked to hepatocellular carcinoma.